Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn Sells 4,720 Shares of Stock

Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn sold 4,720 shares of Phreesia stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $27.31, for a total value of $128,903.20. Following the completion of the sale, the senior vice president now directly owns 110,309 shares in the company, valued at approximately $3,012,538.79. This represents a 4.10 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Amy Beth Vanduyn also recently made the following trade(s):

• On Wednesday, January 15th, Amy Beth Vanduyn sold 604 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total value of $16,295.92.
• On Monday, January 6th, Amy Beth Vanduyn sold 1,311 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total value of $34,885.71.
• On Tuesday, December 3rd, Amy Beth Vanduyn sold 25,447 shares of Phreesia stock. The stock was sold at an average price of $20.93, for a total transaction of $532,605.71.

Phreesia Trading Down 0.2 %

Shares of Phreesia stock opened at $27.29 on Thursday. The company has a 50-day simple moving average of $23.77 and a two-hundred day simple moving average of $22.94. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $29.16. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.04. The business had revenue of $106.80 million during the quarter, compared to analysts’ expectations of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm’s revenue for the quarter was up 16.6% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.58) earnings per share. Equities research analysts predict that Phreesia, Inc. will post -1.1 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Citigroup boosted their price objective on shares of Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research note on Friday, January 10th. Needham & Company LLC restated a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a research note on Friday, January 10th. KeyCorp lifted their target price on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 8th. JMP Securities restated a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a research note on Tuesday, December 10th. Finally, Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and lifted their price objective for the stock from $24.00 to $32.00 in a research report on Wednesday, January 8th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Phreesia presently has a consensus rating of “Buy” and a consensus price target of $31.00.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. Deerfield Management Company L.P. Series C bought a new stake in Phreesia during the second quarter worth about $4,078,000. Champlain Investment Partners LLC lifted its holdings in shares of Phreesia by 4.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock worth $57,062,000 after acquiring an additional 97,847 shares during the period. Sei Investments Co. boosted its position in shares of Phreesia by 135.3% during the 2nd quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock worth $3,505,000 after acquiring an additional 95,058 shares in the last quarter. Squarepoint Ops LLC raised its position in Phreesia by 56.3% during the second quarter. Squarepoint Ops LLC now owns 250,396 shares of the company’s stock valued at $5,308,000 after purchasing an additional 90,215 shares in the last quarter. Finally, State Street Corp lifted its stake in Phreesia by 7.1% during the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock worth $30,256,000 after purchasing an additional 88,517 shares during the last quarter. Institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.